72 related articles for article (PubMed ID: 7326104)
1. [Natural killer activity in patients with malignant melanoma].
Masserini C; Villa ML; Rovini D; Clerici E
Boll Ist Sieroter Milan; 1981; 60(4):307-15. PubMed ID: 7326104
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
[TBL] [Abstract][Full Text] [Related]
3. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
4. Relationship between natural killer cell activity and histological features of lymphocyte infiltration and partial regression of the primary tumor in melanoma patients.
Hersey P; Hobbs A; Edwards A; McCarthy WH; McGovern VJ
Cancer Res; 1982 Jan; 42(1):363-8. PubMed ID: 7053864
[TBL] [Abstract][Full Text] [Related]
5. Natural killer (NK) activity in patients with Hodgkin's disease before, during and after multiple-agent therapy.
Frydecka I; Kotlarek-Haus S; Kuliszkiewicz-Janus M; Kuliczkowski K
Arch Immunol Ther Exp (Warsz); 1990; 38(5-6):407-14. PubMed ID: 2130805
[TBL] [Abstract][Full Text] [Related]
6. Circadian rhythms of cytotoxic activity in peripheral blood mononuclear cells of patients with malignant melanoma.
Gamaleia NF; Skivka LM; Fedorchuk AG; Shishko ED
Exp Oncol; 2006 Mar; 28(1):54-60. PubMed ID: 16614709
[TBL] [Abstract][Full Text] [Related]
7. Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients.
Campillo JA; Martínez-Escribano JA; Moya-Quiles MR; Marín LA; Muro M; Guerra N; Parrado A; Campos M; Frías JF; Minguela A; García-Alonso AM; Alvarez-López MR
Clin Cancer Res; 2006 Aug; 12(16):4822-31. PubMed ID: 16914567
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells.
Konjević G; Mirjacić Martinović K; Jurisić V; Babović N; Spuzić I
Biomarkers; 2009 Jun; 14(4):258-70. PubMed ID: 19489688
[TBL] [Abstract][Full Text] [Related]
9. [Circulating K and NK cells in malignant melanoma using monoclonal antibodies].
Graul A; Orfanos CE
Z Hautkr; 1985 Feb; 60(4):338-47. PubMed ID: 3984439
[TBL] [Abstract][Full Text] [Related]
10. Defects in natural killer cell activity and interferon response in human lung carcinoma and malignant melanoma.
Sibbitt WL; Bankhurst AD; Jumonville AJ; Saiki JH; Saiers JH; Doberneck RC
Cancer Res; 1984 Feb; 44(2):852-6. PubMed ID: 6198076
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell activity depression in peripheral blood and ascites from gastric cancer patients with high TGF-beta 1 expression.
Yoon SJ; Heo DS; Kang SH; Lee KH; Kim WS; Kim GP; Lee JA; Lee KS; Bang YJ; Kim NK
Anticancer Res; 1998; 18(3A):1591-6. PubMed ID: 9673375
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of natural killer activity by tumor-associated lymphoid cells from ascites ovarian carcinomas.
Allavena P; Introna M; Mangioni C; Mantovani A
J Natl Cancer Inst; 1981 Aug; 67(2):319-25. PubMed ID: 6943371
[TBL] [Abstract][Full Text] [Related]
13. [Natural killer (NK) cell activity in the peripheral blood of patients with malignant diseases: melanoma, carcinoma, chronic and acute lymphatic leukemia].
Gabrilovac J
Lijec Vjesn; 1985 Aug; 107(8):323-6. PubMed ID: 3864002
[No Abstract] [Full Text] [Related]
14. Human natural killer cells: a comprehensive review.
Sinkovics JG; Horvath JC
Int J Oncol; 2005 Jul; 27(1):5-47. PubMed ID: 15942642
[TBL] [Abstract][Full Text] [Related]
15. No evidence for an association between natural killer cell activity and prognosis in melanoma patients.
Hersey P; Edwards A; Milton GW; McCarthy WH
Nat Immun Cell Growth Regul; 1983-1984; 3(2):87-94. PubMed ID: 6679887
[TBL] [Abstract][Full Text] [Related]
16. The NK function elucidated with respect to effector cells, target cells and other immunological in vitro tests.
Kristensen E
Tokai J Exp Clin Med; 1983 Dec; 8(5-6):449-53. PubMed ID: 6681340
[TBL] [Abstract][Full Text] [Related]
17. Correlation of suppressed natural killer cell activity with altered host resistance models in B6C3F1 mice.
Wilson SD; McCay JA; Butterworth LF; Munson AE; White KL
Toxicol Appl Pharmacol; 2001 Dec; 177(3):208-18. PubMed ID: 11749120
[TBL] [Abstract][Full Text] [Related]
18. [Natural killer (NK) activity of the peripheral blood lymphocytes in cancer patients].
Song Y
Zhonghua Wai Ke Za Zhi; 1989 Jun; 27(6):357-8, 381-2. PubMed ID: 2479505
[TBL] [Abstract][Full Text] [Related]
19. Social support, psychological distress, and natural killer cell activity in ovarian cancer.
Lutgendorf SK; Sood AK; Anderson B; McGinn S; Maiseri H; Dao M; Sorosky JI; De Geest K; Ritchie J; Lubaroff DM
J Clin Oncol; 2005 Oct; 23(28):7105-13. PubMed ID: 16192594
[TBL] [Abstract][Full Text] [Related]
20. Soluble intercellular adhesion molecule-1 and natural killer cell activity in gastric cancer patients.
Kaihara A; Iwagaki H; Gouchi A; Hizuta A; Isozaki H; Takakura N; Tanaka N
Res Commun Mol Pathol Pharmacol; 1998 Jun; 100(3):283-300. PubMed ID: 9730008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
